← Eichor
Study identifier: NCT07284030 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Psychoeducation and Well-Being After Breast Cancer

Condition: Breast Cancer · Breast Cancer Survivors · Breast - Female  ·  Sponsor: Yasemin Nazli

PhaseNA
Planned participants72
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

This randomized controlled trial evaluates the effectiveness of a web-based psychoeducation program on psychological well-being and quality of life in breast cancer survivors who completed active treatment at least one year earlier. Seventy-two women will be randomly assigned to either a 6-week online psychoeducation program plus standard care or standard care alone. The intervention consists of weekly 30-45 minute online sessions focusing on coping strategies, psychosocial adjustment, quality of life, and psychological well-being. Primary outcomes include psychological well-being, fear of cancer recurrence, quality of life, and hopelessness, assessed at baseline, post-intervention, and 2-month follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Yasemin Nazlı, Clinical Nurse Specialist  ·  +905325025158  ·  yasemin.nazli@st.uskudar.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Breast Cancer Outpatient ClinicIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07284030